Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

VENOFER

IRON SUCROSE

Standard Dose
EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued

Key Takeaways

  • Primary indication: Review priority: N/A Marketing status: Discontinued
  • Approval overview VENOFER is listed in Drugs@FDA under application 021135 (NDA).
  • Review priority: N/A Marketing status: Discontinued Active ingredient IRON SUCROSE Form and strength INJECTABLE;INTRAVENOUS - EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) Sponsor AM REGENT Submission history Latest submission status date: 2026-03-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview VENOFER is listed in Drugs@FDA under application 021135 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient IRON SUCROSE Form and strength INJECTABLE;INTRAVENOUS - EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) Sponsor AM REGENT Submission history Latest submission status date: 2026-03-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.